Quick Answer
Ping An Biomedical Co., Ltd. reported Cash and Equivalents of $164.7 thousand for fiscal year 2025.
Ping An Biomedical Co., Ltd. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $164.7K | +25.8% |
| 2024 | $130.9K | -77.9% |
| 2023 | $591.9K | — |
- Ping An Biomedical Co., Ltd. showed an increase of +25.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, Ping An Biomedical Co., Ltd.’s cash and equivalents has declined by 72.2% (from $591.9 thousand to $164.7 thousand).
- The most recent figure is from Ping An Biomedical Co., Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on January 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: